Centre forms committee to examine WHO details on 66 kid deaths in The Gambia
Darpan News Desk IANS, 12 Oct, 2022 11:00 AM
New Delhi, Oct 12 (IANS) The Centre has formed a four-member panel to examine the detailed report shared by the World Health Organisation on 66 children's deaths in The Gambia reportedly after using Indian-made medicines.
"The committee will examining and analysing adverse event reports, causal relationship, and all related details shared by WHO. After examining, the committee will suitably advise and recommend the Drug Controller General of India (DCGI) about further course of action. The committee may co-opt any other technical expert as deemed necessary, an official source told IANS.
The WHO had issued an alert on four India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 deaths among children in Gambia".
The committee will be chaired by Dr Y.K Gupta, Vice Chairperson, Standing National Committee on Medicines. The other members are Dr Pragya D. Yadav, NIV, ICMR, Pune, Dr Arti Bahl, Division of Epidemiology, NCDC, New Delhi, and A.K. Pradhan, JDC(I), CDSCO.
The WHO has informed that as per the tentative results received by it, out of the 23 samples of the products under reference which were tested, four samples have been found to contain Diethylene Glycol/Ethylene Glycol.
However, the global health body has not yet made available the certificate of analysis. It has informed that the same will be made available in near future. The exact one to one causal relation of death has not yet been provided by the WHO to the Central Drugs Standard Control Organisation (CDSCO) although it has requested the global health body twice in this regard, sources told IANS.
After the CDSCO launched a detailed investigation to ascertain the facts, the preliminary enquiry has revealed that Maiden Pharmaceutical Ltd, Sonepat, Haryana is a manufacturer licensed by the State Drug Controller for products Promethazine Oral Solution BP, Kofexnalin Baby Cough Syrup, MaKoff Baby Cough Syrup, and MaGrip n Cold Syrup under reference, and holds manufacturing permission for these products for export only. The company has manufactured and exported these products only to The Gambia.
Meanwhile, the CDSCO and State Drug Controller Haryana have stopped all the manufacturing activities of Maiden Pharmaceuticals Ltd at Sonepat on October 11 on grounds of deficiencies found on local inspection.
The visa backlog issue is of utmost concern to the Indian students who are trying to return to educational institutions in Australia following the Covid pandemic. Jaishankar, who is on his second visit to Australia, said he was assured that the situation has improved and about 77,000 Indian students are back in Australia.
Deputy Commissioner of Police (DCP) of Special Cell, Jasmeet Singh said that the arrested gangsters, identified as Deepak Arora alias Deepa alias Popat and Gulshan Kumar alias Gulia, were arrested from the Lado Sarai area in the national capital.
BJP leader Bagga had moved the High Court while challenging the non-bailable arrest warrant issued against him by a Mohali Court in May. While pronouncing the judgment in Bagga case, Justice Anoop Chitkara said the court had seen all the tweets and posts placed on record by the parties.
In view of the current escalation of hostilities in Ukraine, Indian nationals are advised to avoid all non-essential travel to and within Ukraine. They must strictly follow the safety and security guidelines issued by the Ukrainian Government and local authorities, the advisory said.
India reported 1,957 fresh Covid cases in the last 24 hours, against 2,424 Covid cases recorded on the previous day, said the Union Health Ministry on Tuesday. In the same period, the country has recorded 8 more Covid related deaths, taking the death toll to 5,28,822 as per the report.
Badal's assertions come in the wake of Haryana Chief Minister Manohar Lal Khattar saying that he will be meeting his Punjab counterpart regarding the Sutlej-Yamuna Link (SYL) canal on October 14 in Chandigarh.
